Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1256

1.

Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 investigators.

Cardiovasc Interv Ther. 2020 Feb 21. doi: 10.1007/s12928-020-00651-9. [Epub ahead of print]

PMID:
32086787
2.

Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates from hospitals in Myanmar.

Tada T, Uchida H, Hishinuma T, Watanabe S, Tohya M, Kuwahara-Arai K, Mya S, Zan KN, Kirikae T, Tin HH.

J Glob Antimicrob Resist. 2020 Feb 18. pii: S2213-7165(20)30040-0. doi: 10.1016/j.jgar.2020.02.011. [Epub ahead of print]

PMID:
32084608
3.

Automatic detection and classification of protruding lesions in wireless capsule endoscopy images based on a deep convolutional neural network.

Saito H, Aoki T, Aoyama K, Kato Y, Tsuboi A, Yamada A, Fujishiro M, Oka S, Ishihara S, Matsuda T, Nakahori M, Tanaka S, Koike K, Tada T.

Gastrointest Endosc. 2020 Feb 18. pii: S0016-5107(20)30132-2. doi: 10.1016/j.gie.2020.01.054. [Epub ahead of print]

PMID:
32084410
4.

Post-Progression Treatment Eligibility of Unresectable Hepatocellular Carcinoma Patients Treated with Lenvatinib.

Hiraoka A, Kumada T, Fukunishi S, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Yokohama K, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K, Kudo M.

Liver Cancer. 2020 Jan;9(1):73-83. doi: 10.1159/000503031. Epub 2019 Oct 18.

5.

Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies.

Kariyama K, Nouso K, Wakuta A, Oonishi A, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Takaguchi K, Tsutsui A, Shimada N, Kumada T.

Liver Cancer. 2020 Jan;9(1):41-49. doi: 10.1159/000502479. Epub 2019 Oct 22.

6.

Neutrophil-lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.

Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Yasuda S, Toyoda H, Fukunishi S, Ohama H, Kawata K, Nakamura S, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Arai T, Imai M, Joko K, Koizumi Y, Hiasa Y.

Liver Int. 2020 Feb 17. doi: 10.1111/liv.14405. [Epub ahead of print]

PMID:
32064740
7.

Artificial-intelligence-based detection of pharyngeal cancer using convolutional neural networks.

Tamashiro A, Yoshio T, Ishiyama A, Tsuchida T, Hijikata K, Yoshimizu S, Horiuchi Y, Hirasawa T, Seto A, Sasaki T, Fujisaki J, Tada T.

Dig Endosc. 2020 Feb 16. doi: 10.1111/den.13653. [Epub ahead of print]

PMID:
32064684
8.

[Current status of AI diagnosis in upper gastrointestinal tract].

Hirasawa T, Yoshio T, Tada T.

Nihon Shokakibyo Gakkai Zasshi. 2020;117(2):141-149. doi: 10.11405/nisshoshi.117.141. Japanese. No abstract available.

PMID:
32037359
9.

Diabetes Mellitus and Long-Term Risk for Heart Failure After Coronary Revascularization.

Takeji Y, Shiomi H, Morimoto T, Furukawa Y, Ehara N, Nakagawa Y, Kato T, Tazaki J, Kato ET, Yaku H, Yoshikawa Y, Tada T, Hanyu M, Kadota K, Komiya T, Ando K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort Investigators.

Circ J. 2020 Jan 29. doi: 10.1253/circj.CJ-19-0980. [Epub ahead of print]

10.

Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma.

Chuma M, Uojima H, Numata K, Hidaka H, Toyoda H, Hiraoka A, Tada T, Hirose S, Atsukawa M, Itokawa N, Arai T, Kako M, Nakazawa T, Wada N, Iwasaki S, Miura Y, Hishiki S, Nishigori S, Morimoto M, Hattori N, Ogushi K, Nozaki A, Fukuda H, Kagawa T, Michitaka K, Kumada T, Maeda S.

Cancers (Basel). 2020 Jan 26;12(2). pii: E293. doi: 10.3390/cancers12020293.

11.

Emergence of clinical isolates of highly carbapenem-resistant Klebsiella pneumoniae co-harboring blaNDM-5 and blaOXA-181 or -232 in Nepal.

Sherchan JB, Tada T, Shrestha S, Uchida H, Hishinuma T, Morioka S, Shahi RK, Bhandari S, Twi RT, Kirikae T, Sherchand JB.

Int J Infect Dis. 2020 Jan 23;92:247-252. doi: 10.1016/j.ijid.2020.01.040. [Epub ahead of print]

12.

Application of artificial intelligence using convolutional neural networks in determining the invasion depth of esophageal squamous cell carcinoma.

Tokai Y, Yoshio T, Aoyama K, Horie Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Tsuchida T, Hirasawa T, Sakakibara Y, Yamada T, Yamaguchi S, Fujisaki J, Tada T.

Esophagus. 2020 Jan 24. doi: 10.1007/s10388-020-00716-x. [Epub ahead of print]

PMID:
31980977
13.

Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.

Atsukawa M, Tsubota A, Takaguchi K, Toyoda H, Iwasa M, Ikegami T, Chuma M, Nozaki A, Uojima H, Hiraoka A, Fukunishi S, Yokohama K, Tada T, Kato K, Abe H, Tani J, Okubo H, Watanabe T, Hattori N, Tsutsui A, Senoh T, Yoshida Y, Okubo T, Itokawa N, Nakagawa-Iwashita A, Kondo C, Arai T, Michitaka K, Iio E, Kumada T, Tanaka Y, Takei Y, Iwakiri K.

J Gastroenterol Hepatol. 2019 Dec 27. doi: 10.1111/jgh.14965. [Epub ahead of print]

PMID:
31881554
14.

Palladium-bearing intermetallic electride as an efficient and stable catalyst for Suzuki cross-coupling reactions.

Ye TN, Lu Y, Xiao Z, Li J, Nakao T, Abe H, Niwa Y, Kitano M, Tada T, Hosono H.

Nat Commun. 2019 Dec 11;10(1):5653. doi: 10.1038/s41467-019-13679-0.

15.

The chances of hepatic resection curing hepatocellular carcinoma.

Cucchetti A, Zhong J, Berhane S, Toyoda H, Shi K, Tada T, Chong CCN, Xiang BD, Li LQ, Lai PBS, Ercolani G, Mazzaferro V, Kudo M, Cescon M, Pinna AD, Kumada T, Johnson PJ.

J Hepatol. 2019 Nov 30. pii: S0168-8278(19)30703-2. doi: 10.1016/j.jhep.2019.11.016. [Epub ahead of print]

PMID:
31790765
16.

HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication.

Ogawa E, Toyoda H, Iio E, Jun DW, Huang CF, Enomoto M, Hsu YC, Haga H, Iwane S, Wong G, Lee DH, Tada T, Liu CH, Chuang WL, Hayashi J, Cheung R, Yasuda S, Tseng CH, Takahashi H, Tran S, Yeo YH, Henry L, Barnett SD, Nomura H, Nakamuta M, Dai CY, Huang JF, Yang HI, Lee MH, Jung Jun M, Kao JH, Eguchi Y, Ueno Y, Tamori A, Furusyo N, Yu ML, Tanaka Y, Nguyen MH; REAL-C Investigators, Ahn SB, Azuma K, Dohmen K, Yoon Jeong J, Jung JH, Kajiwara E, Kato M, Kawano A, Koyanagi T, Ooho A, Park SH, Satoh T, Shimoda S, Song DS, Takahashi K, Yeh ML, Yoon EL.

Clin Infect Dis. 2019 Nov 28. pii: ciz1160. doi: 10.1093/cid/ciz1160. [Epub ahead of print]

PMID:
31777940
17.

Plasma and tumoral glypican-3 levels are correlated in patients with hepatitis C virus-related hepatocellular carcinoma.

Shimizu Y, Mizuno S, Fujinami N, Suzuki T, Saito K, Konishi M, Takahashi S, Gotohda N, Tada T, Toyoda H, Kumada T, Miura M, Suto K, Yamaji T, Matsuda T, Endo I, Nakatsura T.

Cancer Sci. 2020 Feb;111(2):334-342. doi: 10.1111/cas.14251. Epub 2019 Dec 28.

18.

Automatic detection of blood content in capsule endoscopy images based on a deep convolutional neural network.

Aoki T, Yamada A, Kato Y, Saito H, Tsuboi A, Nakada A, Niikura R, Fujishiro M, Oka S, Ishihara S, Matsuda T, Nakahori M, Tanaka S, Koike K, Tada T.

J Gastroenterol Hepatol. 2019 Nov 23. doi: 10.1111/jgh.14941. [Epub ahead of print]

PMID:
31758717
19.

Low-Temperature Synthesis of Perovskite Oxynitride-Hydrides as Ammonia Synthesis Catalysts.

Kitano M, Kujirai J, Ogasawara K, Matsuishi S, Tada T, Abe H, Niwa Y, Hosono H.

J Am Chem Soc. 2019 Dec 26;141(51):20344-20353. doi: 10.1021/jacs.9b10726. Epub 2019 Nov 22.

PMID:
31755269
20.

Effect of Statins on Recurrent Venous Thromboembolism (from the COMMAND VTE Registry).

Yoshikawa Y, Yamashita Y, Morimoto T, Mabuchi H, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Murakami T, Kimura T; COMMAND VTE Registry Investigators.

Am J Cardiol. 2020 Jan 15;125(2):189-197. doi: 10.1016/j.amjcard.2019.10.011. Epub 2019 Oct 30.

PMID:
31744599
21.

Application of the Academic Research Consortium High Bleeding Risk Criteria in an All-Comers Registry of Percutaneous Coronary Intervention.

Natsuaki M, Morimoto T, Shiomi H, Yamaji K, Watanabe H, Shizuta S, Kato T, Ando K, Nakagawa Y, Furukawa Y, Tada T, Nagao K, Kadota K, Toyofuku M, Kimura T.

Circ Cardiovasc Interv. 2019 Nov;12(11):e008307. doi: 10.1161/CIRCINTERVENTIONS.119.008307. Epub 2019 Nov 11.

PMID:
31707804
22.

Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry.

Yamashita Y, Murata K, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Nawada R, Onodera T, Kimura T; COMMAND VTE Registry Investigators.

Thromb Res. 2019 Dec;184:50-57. doi: 10.1016/j.thromres.2019.10.029. Epub 2019 Nov 1.

PMID:
31706068
23.

Liver stiffness does not affect ultrasound-guided attenuation coefficient measurement in the evaluation of hepatic steatosis.

Tada T, Kumada T, Toyoda H, Yasuda S, Sone Y, Hashinokuchi S, Ogawa S, Oguri T, Kamiyama N, Chuma M, Akita T, Tanaka J.

Hepatol Res. 2020 Feb;50(2):190-198. doi: 10.1111/hepr.13442. Epub 2019 Dec 29.

PMID:
31661724
24.

Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.

Tada T, Kumada T, Hiraoka A, Michitaka K, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y.

Hepatol Res. 2020 Jan;50(1):75-83. doi: 10.1111/hepr.13427. Epub 2019 Dec 6.

PMID:
31660700
25.

Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer: From the COMMAND VTE Registry.

Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Nishimoto Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Chest. 2019 Oct 9. pii: S0012-3692(19)34003-6. doi: 10.1016/j.chest.2019.08.2206. [Epub ahead of print]

PMID:
31605702
26.

The emergence of non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI in patients with chronic hepatitis C.

Toyoda H, Tada T, Yasuda S, Mizuno K, Sone Y, Kaneoka Y, Maeda A, Akita T, Tanaka J, Kumada T.

Aliment Pharmacol Ther. 2019 Dec;50(11-12):1232-1238. doi: 10.1111/apt.15490. Epub 2019 Oct 6.

PMID:
31588590
27.

Endoscopic detection and differentiation of esophageal lesions using a deep neural network.

Ohmori M, Ishihara R, Aoyama K, Nakagawa K, Iwagami H, Matsuura N, Shichijo S, Yamamoto K, Nagaike K, Nakahara M, Inoue T, Aoi K, Okada H, Tada T.

Gastrointest Endosc. 2020 Feb;91(2):301-309.e1. doi: 10.1016/j.gie.2019.09.034. Epub 2019 Oct 1.

PMID:
31585124
28.

Convolutional Neural Network for Differentiating Gastric Cancer from Gastritis Using Magnified Endoscopy with Narrow Band Imaging.

Horiuchi Y, Aoyama K, Tokai Y, Hirasawa T, Yoshimizu S, Ishiyama A, Yoshio T, Tsuchida T, Fujisaki J, Tada T.

Dig Dis Sci. 2019 Oct 4. doi: 10.1007/s10620-019-05862-6. [Epub ahead of print]

PMID:
31584138
29.

D-dimer levels at diagnosis and long-term clinical outcomes in venous thromboembolism: from the COMMAND VTE Registry.

Oi M, Yamashita Y, Toyofuku M, Morimoto T, Motohashi Y, Tamura T, Kaitani K, Amano H, Takase T, Hiramori S, Kim K, Akao M, Kobayashi Y, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

J Thromb Thrombolysis. 2019 Sep 30. doi: 10.1007/s11239-019-01964-0. [Epub ahead of print]

PMID:
31571121
30.

Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients With High Bleeding Risk: Insight From the STOPDAPT-2 Trial.

Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 Investigators.

Circulation. 2019 Dec 3;140(23):1957-1959. doi: 10.1161/CIRCULATIONAHA.119.043613. Epub 2019 Sep 27. No abstract available.

PMID:
31560216
31.

Cancer-Associated Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.

Sakamoto J, Yamashita Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Nishimoto Y, Sasa T, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Tamura T, Nakagawa Y, Kimura T; COMMAND VTE Registry Investigators.

Circ J. 2019 Oct 25;83(11):2271-2281. doi: 10.1253/circj.CJ-19-0515. Epub 2019 Sep 20.

32.

Long-Term Incidence and Details of Bleeding Events After Everolimus-Eluting Stent Implantation - 7-8-Year Outcomes.

Miura K, Shimada T, Ohya M, Murai R, Amano H, Kubo S, Tada T, Tanaka H, Fuku Y, Goto T, Kadota K.

Circ J. 2019 Oct 25;83(11):2242-2249. doi: 10.1253/circj.CJ-19-0494. Epub 2019 Sep 7.

33.

Evaluation of a new selective agar medium for detection of carbapenem-resistant Enterobacteriaceae.

Kuwahara-Arai K, Morito A, Yanagisawa I, Hishinuma T, Mya S, Zan KN, Tohya M, Tada T, Tin HH, Sekiguchi JI, Watanabe S, Kirikae T.

Diagn Microbiol Infect Dis. 2019 Dec;95(4):114882. doi: 10.1016/j.diagmicrobio.2019.114882. Epub 2019 Aug 7.

PMID:
31495528
34.

Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Koizumi Y, Hiasa Y, Michitaka K; On behalf of the Real-Life Practice Experts for HCC (RELPEC) Study Group and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019;97(6):334-340. doi: 10.1159/000502095. Epub 2019 Aug 29.

PMID:
31466068
35.

Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium.

Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, Hayashi J, Tseng CH, Yasuda S, Tran S, Kam L, Henry L, Jeong JY, Nomura H, Park SH, Nakamuta M, Huang JF, Tai CM, Lo GH, Lee MH, Yang HI, Kao JH, Tamori A, Eguchi Y, Ueno Y, Furusyo N, Tanaka Y, Yu ML, Nguyen MH; REAL-C Investigators.

Hepatol Int. 2019 Sep;13(5):587-598. doi: 10.1007/s12072-019-09974-z. Epub 2019 Aug 28.

PMID:
31463665
36.

Clinical usefulness of a deep learning-based system as the first screening on small-bowel capsule endoscopy reading.

Aoki T, Yamada A, Aoyama K, Saito H, Fujisawa G, Odawara N, Kondo R, Tsuboi A, Ishibashi R, Nakada A, Niikura R, Fujishiro M, Oka S, Ishihara S, Matsuda T, Nakahori M, Tanaka S, Koike K, Tada T.

Dig Endosc. 2019 Aug 23. doi: 10.1111/den.13517. [Epub ahead of print]

PMID:
31441972
37.
38.

Enriched bovine IgG fraction prevents infections with Enterohaemorrhagic Escherichia coli O157:H7, Salmonella enterica serovar Enteritidis, and Mycobacterium avium.

Funatogawa K, Tada T, Kuwahara-Arai K, Kirikae T, Takahashi M.

Food Sci Nutr. 2019 Jul 17;7(8):2726-2730. doi: 10.1002/fsn3.1134. eCollection 2019 Aug.

39.

Artificial intelligence using a convolutional neural network for automatic detection of small-bowel angioectasia in capsule endoscopy images.

Tsuboi A, Oka S, Aoyama K, Saito H, Aoki T, Yamada A, Matsuda T, Fujishiro M, Ishihara S, Nakahori M, Koike K, Tanaka S, Tada T.

Dig Endosc. 2019 Aug 7. doi: 10.1111/den.13507. [Epub ahead of print]

PMID:
31392767
40.

Visualization of sequential conversion of human intermediately reprogrammed stem cells into iPS cells.

Teshigawara R, Hirano K, Nagata S, Huang D, Tada T.

Genes Cells. 2019 Oct;24(10):667-673. doi: 10.1111/gtc.12716. Epub 2019 Sep 1.

PMID:
31386786
41.

Pseudomonas juntendi sp. nov., isolated from patients in Japan and Myanmar.

Tohya M, Watanabe S, Teramoto K, Shimojima M, Tada T, Kuwahara-Arai K, War MW, Mya S, Tin HH, Kirikae T.

Int J Syst Evol Microbiol. 2019 Nov;69(11):3377-3384. doi: 10.1099/ijsem.0.003623.

PMID:
31368883
42.

Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular Carcinoma.

Hiraoka A, Kumada T, Atsukawa M, Hirooka M, Tsuji K, Ishikawa T, Takaguchi K, Kariyama K, Itobayashi E, Tajiri K, Shimada N, Shibata H, Ochi H, Tada T, Toyoda H, Nouso K, Tsutsui A, Nagano T, Itokawa N, Hayama K, Imai M, Joko K, Tanaka H, Tamai T, Koizumi Y, Hiasa Y, Michitaka K, Kudo M; Real-life Practice Experts for HCC (RELPEC) Study Group; HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

Oncology. 2019;97(5):277-285. doi: 10.1159/000501281. Epub 2019 Jul 15.

PMID:
31307035
43.

Long-term outcomes of three-vessel coronary artery disease after coronary revascularization by percutaneous coronary intervention using second-generation drug-eluting stents versus coronary artery bypass graft surgery.

Hata R, Kubo S, Tsuneyoshi H, Shimamoto T, Kuwayama A, Ohya M, Shimada T, Miura K, Amano H, Otsuru S, Habara S, Tada T, Tanaka H, Fuku Y, Goto T, Komiya T, Kadota K.

Cardiovasc Interv Ther. 2019 Jul 10. doi: 10.1007/s12928-019-00599-5. [Epub ahead of print]

PMID:
31292929
44.

Clinical Characteristics of Pars Tensa Cholesteatoma: A Comparative Study of Area-Based Classification Systems Proposed by the Japanese Otological Society and the European Academy of Otology - Neuro-Otology.

Motegi M, Yamamoto Y, Tada T, Takahashi M, Sampei S, Sano H, Morino T, Komori M, Miura M, Yamamoto K, Yaguchi Y, Sakurai Y, Kojima H.

J Int Adv Otol. 2019 Aug;15(2):184-188. doi: 10.5152/iao.2019.6349.

45.

Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.

Ikeda H, Watanabe T, Atsukawa M, Toyoda H, Takaguchi K, Nakamuta M, Matsumoto N, Okuse C, Tada T, Tsutsui A, Yamashita N, Kondo C, Hayama K, Kato K, Itokawa N, Arai T, Shimada N, Asano T, Uojima H, Ogawa C, Mikami S, Ikegami T, Fukunishi S, Asai A, Iio E, Tsubota A, Hiraoka A, Nozaki A, Okubo H, Tachi Y, Moriya A, Oikawa T, Matsumoto Y, Tsuruoka S, Tani J, Kikuchi K, Iwakiri K, Tanaka Y, Kumada T.

J Viral Hepat. 2019 Nov;26(11):1266-1275. doi: 10.1111/jvh.13170. Epub 2019 Aug 9.

PMID:
31278795
46.

Thrombolysis with tissue plasminogen activator in patients with acute pulmonary embolisms in the real world: from the COMMAND VTE registry.

Nishimoto Y, Yamashita Y, Morimoto T, Saga S, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Izumi T, Tada T, Chen PM, Murata K, Tsuyuki Y, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Yoshikawa Y, Shiomi H, Kato T, Makiyama T, Ono K, Sato Y, Kimura T; COMMAND VTE Registry Investigators.

J Thromb Thrombolysis. 2019 Nov;48(4):587-595. doi: 10.1007/s11239-019-01913-x.

PMID:
31278648
47.

Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.

Tada T, Iijima H, Kobayashi N, Yoshida M, Nishimura T, Kumada T, Kondo R, Yano H, Kage M, Nakano C, Aoki T, Aizawa N, Ikeda N, Takashima T, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Nishikawa H, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Ultrasound Med Biol. 2019 Oct;45(10):2679-2687. doi: 10.1016/j.ultrasmedbio.2019.05.033. Epub 2019 Jul 3.

PMID:
31277922
48.

Natural history of liver-related disease in patients with chronic hepatitis C virus infection: An analysis using a Markov chain model.

Tada T, Toyoda H, Yasuda S, Miyake N, Kumada T, Kurisu A, Ohisa M, Akita T, Tanaka J.

J Med Virol. 2019 Oct;91(10):1837-1844. doi: 10.1002/jmv.25533. Epub 2019 Jul 16.

49.

Assessment of a newly developed immunochromatographic assay for NDM-type metallo-β-lactamase producing Gram-negative pathogens in Myanmar.

Tada T, Sekiguchi JI, Watanabe S, Kuwahara-Arai K, Mizutani N, Yanagisawa I, Hishinuma T, Zan KN, Mya S, Tin HH, Kirikae T.

BMC Infect Dis. 2019 Jun 28;19(1):565. doi: 10.1186/s12879-019-4147-4.

50.

The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.

Yamashita Y, Yoshikawa Y, Morimoto T, Amano H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, Toyofuku M, Tada T, Chen PM, Murata K, Tsuyuki Y, Saga S, Sasa T, Sakamoto J, Kinoshita M, Togi K, Mabuchi H, Takabayashi K, Shiomi H, Kato T, Makiyama T, Ono K, Kimura T; COMMAND VTE Registry Investigators.

Int J Cardiol. 2019 Oct 1;292:198-204. doi: 10.1016/j.ijcard.2019.06.032. Epub 2019 Jun 13.

PMID:
31239211

Supplemental Content

Support Center